Learn Pharmaceutical Marketing - Teach yourself Information            Way of Success         Tackle the Tough one first

 

Chairman PPMA Mr. Haroon Qasim puts light on Pakistan's 1st Pharma Summit A
Prices of Pharmacuetical products should be revised, Lt Col (R) Zafar Baloch TI (M)	Better promotion & administrative arrangements can produce better results, Tariq Naeem Jaura

KKF serving humanity without any prejudice or discrimination, Syed Mustafa Kamal visits Health Asia Exhibition
Syed Mustafa Kamal, Former City Nazim & Managing Trustee of KKF said that following Mr. Altaf Hussain's ideological and philosophical approach KKF encompasses the concept of service to humanity without any prejudice or discrimination. He expressed these views while visiting KKF Pavilion in 7th Health Asia at Karachi Expo Centre.
KKF has been providing free medical treatment and medicines to the less privileged through mobile dispensaries and field hospitals, patients are also operated in mobile dispensaries as and when needed in emergency, as well as rendering mortuary services on humanitarian ground, he added. He opined that Khidmat-e-Khalq Foundation (KKF) is a highly organized, active and effective social welfare organization engaged in diversified social welfare activities including but not limited to just operations of ambulance and coffin carrier services, hospitals, dispensaries, blood bank, mortuaries and so on.
Other than the trade visitors, KKF stand was visited by a number of dignitaries, diplomats including Ambassador of Sudan, Mohammed Omer Musa and Trustee of KKF, Mr. Arshad Vohra.
While briefing the activities of KKF in Health Asia, Imran Usman, Director Operations KKF stated that it is our second time participation in Health Asia and we found it very helpful in creating awareness about our services among corporate sector & public.Besides creating awareness, we are conducting free eye testing and blood group tests here at KKF Pavilion. Besides the new addition of Ambulance in our fleet is being displayed here, Imran Usman added.
On behalf of Organizers, Shield was presented to Syed Mustafa Kamal by Adeeb Aijaz, GM Communication & Media, Ecommerce Gateway. Umair Nizam, VP EC Gateway was also present.

7th HEALTH ASIA 2011 Exhibition & Conference
7th Health Asia 2011 Int’l Exhibition & Conference
Sindh Minister for Health Dr. Sagheer Ahmed inaugurated the Event.
Karachi : Sindh Minister for Health Dr. Sagheer Ahmed inaugurated 7th Health Asia 2011 Int’l Exhibition & Conference today at Karachi Expo Centre. Delegates from more than 20 countries are attending the Event.
The Chief Guest then inaugurated Sindh Health Department Pavilion. Secretary Health Syed Hashim Raza Zaidi, President Ecommerce Gateway Dr. Khursheed Nizam and others were also present at the occasion.
Dr. Sagheer Ahmed visited the stalls and met international & domestic exhibitors who are showcasing their products and services. Dr. Sagheer Ahmed said that the attendance of foreign delegates on Health Asia is a warm health sign which should grow and loom large with the passage of time. Dr. Sagheer also said that the eradication of polio from Pakistan is very much on the agenda of government and in this aspect government is importing P1-P3 polio vaccination from foreign countries .And I am hopeful this will act as a refreshing step towards Polio free Pakistan. Lastly, he encouraged the commencement of such events and also appreciated the efforts of Ecommerce Gateway. Around 70 foreign delegates from 20 countries including China, Taiwan, India, UAE and more were also introduced to the Chief Guest. The Event is open only for Trade Corporate Visitors from 10 AM to 7 PM daily. More than 35,000 visitors are expected to visit the event during the 3 days.
Health Asia Int’l Exhibition is the only UFI (Paris) Approved Health & Pharma sector Event in Pakistan, which provides enormous opportunities of learning, information sharing, mutual cooperation and combined projects to all the stakeholders in the Asian Health sector. Since its inception, the event has proved to be the best across the entire spectrum of Health Care as it integrates delivering the best interactive opportunities to participants and an ideal environment to the audiences. In short, the exhibition delivers to exhibitors, the right balance between Health industries players, senior decision makers and practitioners.
7th Health Asia 2011 Int’l Exhibition & Conferences is being organized by Ecommerce Gateway Pakistan (Pvt) Ltd. with the support of Ministry of Health Government of Sindh, Trade Development Authority of Pakistan, Pharma Bureau of Information and Statistics, Board of Investment, Pakistan Pharmaceutical Manufacturers Association, National University Hospital Singapore, Smart Health Care, Parkway Health Singapore, Tan Tock Seng Hospital, Members of National Healthcare Group, Pakistan Standards & Quality Control Authority, Pakistan Surgical Manufacturers Association and Jamal’s Yellow Pages of Pakistan. The Sponsors of the Event are Stiefel (GSK), Abbott, Physionics, South City Hospital and Morgan Chemicals.
 

The exhibitors and visitors praised the platform of Health Asia, as the event certainly provide tremendous opportunity for the local industry to grow and explore new horizon by interacting with international companies. Although exhibitors also shown their concerns over improvement in promotional and administrative arrangements to obtain better results and turnout of participants and visitors.
Health Asia is the biggest ever health event in the history of Pakistan which provides enormous opportunities of learning, information sharing & cooperation and match making to all the stakeholders in the Asian health sector.
The Event comprised Conferences on latest research & developments / innovations on health, medicine, laboratory technology, diagnostics, surgery, transplants, physiotherapy, patients’ referrals, diets etc. Delegations from Ministry of Health of OIC and Asian Countries, Hospitals of international repute, Medical Institutions, Pharmaceutical Companies are major participants of Health Asia 2010.

فارماکی صنعت کو درپیش مسائل کے حل کیلئے بھرپور کوشیشں کی جائیگی، سینیٹر غلام علی
صوبوں کے درمیان یکساں پالیسی کے لئے ڈرگ کنٹرول اتھارٹی قائم کی جائے ہارون قاسم
کراچی (جیوے پاکستان) فیڈریشن آف چمبرز آف کامرس اینڈ انڈسٹریز کے صدر سینیٹر غلام علی نے کہا ہے کہ فارما انڈسٹری کے مسائل انتہائی اہمیت کے حامل ہیں اور انکو حل کرنے کے لئے ایف پی سی سی آئی بھر پور تعاون کرئیگی اوربالخصوص 18 ویں ترمیم کے حوالے سے صوبوں کی وزارت منتقل کرنے سے جن گھمبیر مسائل کا خطرہ ہے انکا جائزہ لیا جارہا ہے ۔ اور جلد ہی سینیٹررضا ربانی سے ملاقات کرکے اسے حل کرنے کی کوشش کی جائیگی۔ یہ بات انہوں نے فیڈریشن ہاؤس میں پاکستان فارما سیوٹیکل مینو فیکچررز اسیوسی ایشن کے وفد سے ملاقات کے دوران کہی ۔ وفد نے چیرمین ہارون قاسم کی قیادت میں صدر ایف پی سی سی آئی سے ملاقات کی ۔ اس موقع پر ریجینل چیرمین ڈاکٹر قیصر وحید بھی موجود تھے ۔ چیرمین پی پی ایم اے نے سینیٹر غلام علی کی توجہ اس طرف مبذول کرائی کہ وفاقی صحت کی صوبوں کو منتقلی سے ادویات کی رجسٹریشن ، پالیسی ، معیار اور قیمتوں کے حوالے سے فارما انڈسٹری کے لئے سنگین مسائل پیدا ہونگے اور ہر فارما کی انڈسٹری کو چاروں صوبوں کے علاوہ اسلام آباد ،ّ زاد کشمیر ، گلگلت بلتستان میں الگ الگ طریقہ کار اور پالیسی کا سامنا ہوگا ۔ اور پی پی ایم اے اسی صورتحال کو انتہائی تشویش سے دیکھ رہی ہے ۔ ہارون قاسم نے کہا کہ فارما انڈسٹری کو اسی بحران سے بچانے کے لئے ڈرگ کنٹرول اتھارٹی تشکیل دی جائے ۔ جو قیمتوں کے تعین ، معیار اور رجسٹریشن کے معیار کو تما م صوبوں پر عمل درآمد کرائیں ۔ انہوں نے کہا ہم 18ویں ترمیم کے خلاف نہیں بلکہ ہم صرف اس کے تحت متوقع مسائل کا حل چاہتے ہیں ۔ کیونکہ اگر کوئی حل نہ نکالا گیا تو ہر صوبے میں ادویات کا معیار اور قمیتں الگ الگ ہونگی اور برآمدات میں مشکل کا سامنا کرنا پڑیگا انہوں نے نے بتایا کہ امریکہ سمیت دنیا کے کئی ملکوں میں ایک ہی وفاقی ادارہ تمام صوبوں کو حکمت عملی و پالیسی کے فرائض انجام دیتا ہے ۔ ایف پی سی سی آئی کے صدر نے کیا فار ما انڈسٹری ملک کی ادویات کی 90فیصد طلب پوری کررہی ہے اور 5لاکھافراد اس سے وابستہ ہیں اور اسکو آنے والے خطرات سے بچانا ضروری ہے اور اسکے لئے ہم پوری کوشیش کریں گے ۔ اس موقع پر نائب صدر ایف پی سی سی آئی خالد تواب بھی موجود تھے ۔
 

An Exclusive Interview with Mr. Haroon Qasim, Chairman PPMA 1	An Exclusive Interview with Mr. Haroon Qasim, Chairman PPMA 2	An Exclusive Interview with Mr. Haroon Qasim, Chairman PPMA 3	An Exclusive Interview with Mr. Haroon Qasim, Chairman PPMA 4

Acino Pharma concludes Agreement with Highnoon Laboratories in Pakistan
Acino Pharma of Switzerland (www.acino-pharma.com), a company specializing in the development of advanced pharmaceutical formulations in the fields of oncology, acute pain management and palliative care, has concluded an Agreement with Highnoon Laboratories Limited (www.highnoon-labs.com) to make available its product portfolio in Pakistan. Highnoon Laboratories Limited is a leading marketer of high-quality prescription drugs in Pakistan manufacturing drugs under license for several world renowned companies for the last 26 years.
In Lahore this week was Mr. Salman Bokhari, Regional Director Asia Business for Acino Pharma Asia, who held detailed discussions with Chairman of Highnoon Laboratories Limited Mr. Tausif Ahmad Khan and the senior management to finalize arrangements to make available the Acino Pharma brands in Pakistan. Acino Pharma products, comprising high-quality brands of Swiss & European origin, are designed to help patients in need of specialized medicines at fair prices.
Acino is specialized on the development, registration and manufacture of innovative pharmaceuticals using advanced drug delivery technologies for which Acino holds patents. With a focus on solid dosage forms with modified release of the active ingredient, transdermal therapeutic patches and biodegradable subcutaneous implants, Acino markets its products through well-known local partners in Europe, Middle East and Asia. Besides own products, Acino also offers a comprehensive range of services, comprising state-of-the-art product development, contract manufacturing, packaging and logistics.
The Acino Group is headquartered in Basle, Switzerland, currently employing approximately 450 staff and generated annual net revenues of about EUR 160 million in 2009. Acino Holding Ltd., the Group’s parent, is listed on the SIX Swiss Exchange (SIX: ACIN).
As a leading pharmaceutical company, Highnoon is ranked the 13th largest pharmaceutical company by turnover in Pakistan among over 600 registered pharmaceutical players in the market. Highnoon has established brands in the cardiovascular, gastrointestinal, respiratory, and anti-infective therapeutic segments and represents several well-known multinational pharmaceutical companies in Pakistan. Highnoon is a publicly listed company in Pakistan with over 900 employees. The annual turnover of the company is in excess of Rs. 2.5 billion-, equivalent to approx. USD 30 million.

 

Pakistan Academy of Family Physicians Press Con in Lahore Press Club 1	Pakistan Academy of Family Physicians Press Con in Lahore Press Club 2	Pakistan Academy of Family Physicians Press Con in Lahore Press Club 3	Syed Babar Ali Bukhari.PACIFIC Pharmaceuticals Ltd.in PC Lahore	21st International Conference On Family Medicine In Royal Palm 1	21st International Conference On Family Medicine In Royal Palm 2

Pfizer Animal Health Expands Global Commitment To A Safe Food
Supply With A New Focus On Healthy Fish
Acquires Canada-based Microtek, a Leading Researcher, Developer and Manufacturer of Vaccines for Global Aquaculture NEW YORK, N.Y., May 25 - Pfizer Animal Health today announced its acquisition of Microtek International, Inc., a recognized innovator in aquaculture vaccines, R&D and healthcare diagnostic services. The acquisition further expands Pfizer’s commitment to a safe food supply from healthy beef and dairy cattle, swine, poultry and, now, fish. Total global fish production – largely for human consumption – now exceeds that of pork, poultry, beef or dairy. Farmed fish production is becoming increasingly important in meeting global demand and is anticipated to account for 55% of total fish production by 2017, according to industry sources.“The time is right for Pfizer Animal Health to enter the global market for aquaculture healthcare therapeutics,” said Juan Ramón Alaix, president, Pfizer Animal Health. “The integration of Microtek R&D into Pfizer Animal Health also will allow us to build a more diverse and innovative portfolio in biopharmaceuticals. The meat, dairy, egg and fish products that people enjoy for healthy living begin with a healthy food animal.” William Kay, Ph.D., president and chief executive officer, Microtek, who will continue to serve Pfizer in a consultant role, said, “Microtek not only brings to Pfizer Animal Health industryleading vaccines and technology, but also complements Pfizer’s portfolio of health services and diagnostics for food animal production.” Terms of Pfizer Animal Health’s acquisition of Microtek were not disclosed.A growing Pfizer global commitment to safe food According to Mr. Alaix, during the last three years, Pfizer Animal Health has continued to expand its commitment to a safe food supply. In addition to acquiring last year a substantial portion of Wyeth/Fort Dodge Animal Health’s biological and pharmaceutical R&D, manufacturing and food animal products and services, Pfizer Animal Health also: Earlier this year, expanded into global, animal health generic medicines by acquiring R&D and a product line-up from Vetnex Animal Health Limited in India; In 2008, established Pfizer Animal Genetics, helping breeders focus on high-quality beef cattle production with genetic markers, by acquiring R&D and technology from Catapult Genetics, Pty., Ltd., in Australia, and Bovigen, LLC, in the U.S.;And in 2007, enhanced a growing Pfizer Poultry Health business by acquiring R&D and innovative in-ovo vaccination technology from Embrex, Inc, in the U.S.About Microtek Microtek International, Inc. is a privately-held company based in British Columbia, Canada, with commercialized vaccines across a number of fish species. Novel, efficient vaccine injection, oral or immersion delivery systems help to ensure long-term protection of disease in fish across Canada, the U.S., Chile, and parts of Europe. Microtek has a robust product pipeline focused on addressing unmet or underserved needs in farmed fish health. An extensive Microtek research network also includes alliances with leading universities in Canada, U.S. and in Europe. For more information, visit www.Microtek-Intl.com. About Pfizer Animal Health Pfizer, Inc. (NYSE: PFE), the world’s largest research-based biomedical and pharmaceutical company, also is a world leader in discovering and developing innovative animal vaccines and prescription medicines, investing an estimated $300 million annually. In the first quarter of 2010, Pfizer Animal Health generated revenue of $846 million, and for full-year 2009, $2.8 billion, including revenue from Wyeth/Fort Dodge since Pfizer’s acquisition in October.In addition to helping assure a safe, global food supply from healthy food animals, Pfizer Animal Health also helps dogs, cats and horses to live healthy longer. For additional information on Pfizer’s portfolio of animal products and services, visit
www.PfizerAnimalHealth.com.

Zafa Pharmaceuticals Held a Lucky Draw at its Head Office

Zafa Pharmaceuticals Pvt Ltd Pakistan's first multinational company is running a lucky draw scheme for trade level nowadays. In this connection a lucky draw held in its head office. Mr. Shakil Haroon chairman Pakistan chemists and druggists association central zone was the chief guest at this occasion.Mr. Jawad Md Zafa Pharma and his management team was also present. M. Jawad Ameen MD Zafa Pharam talking to Jeevey Pakistan team said that Zafa Pharma is holding 90% market ratio of oral family planning pills in Pakistan. Zafa Pharmaceutical is running its scheme for its Famila brand of birth controle. The chief Guest Mr. Shakil did the lucky draws for the fortunate winners. He also talked at this moment to Jeevey Pakistan and said that PCDA looks after the pharma business from top to bottom and praised Zafa's current activity as this kind of activity enhance the moral of traders and they take more interest in national cause of birth controle by participating the activity in this regard.

On 75% Medicine The consumer will have to pay the VAT - Zahid Saeed

Zahid Saeed Indus pharma- 15-03-2010

PPMA seeks consistent pricing, import, vitamins policy

KARACHI,  Pakistan Pharmaceutical Manufacturers Association (PPMA) has urged the government to announce a long term "pricing policy", "import policy" and "vitamins policy" for pharmaceutical industry.
Addressing a press conference here Tuesday, newly elected president PPMA, Mian Asad Shuja-ur-Rehman said that there is no pricing revision for drugs since 1991 and warned that the industry was will face a sluggish growth if prices are not revised upward.
He said that local pharmaceutical industry was growing at a rate of 17 percent while pharma exports were progressing at 15 percent annually.
He claimed that the share of local national pharmaceutical industry in the total medicine production has enhanced from 18 percent to more than 60 percent while the share of multinational companies (MNCs) has declined from 82 percent to 40 percent.He said that quality and standards of local national pharma industry were very high and therefore, they are producing drugs for several MNCs in the country."This growth can be reversed or stopped if prices are not reviewed", he said and added that Supreme Court of Pakistan has given a three-month time to the government to announce pricing policy for drugs.Similarly, he said that the government has to announce its import policy and vitamins policy for drugs so that local manufacturers should take decision on the basis of this framework.Rehman suggested that the government should not include those medicines in the import list which are being manufactured in the country by 20 to 25 local national companies. Only those drugs should be allowed for imports which are not manufactured locally.He pointed out that registration of new drugs was almost stopped as the "registration board" did not have a meeting for the past eight months. This has also badly affected the local national pharma industry as companies cannot begin production of new drug in Pakistan, he noted.Responding to a question about the allegation against local companies for producing spurious drugs, PPMA chairman said that less than "one percent" of the total drugs manufactures in Pakistan were fake or substandard.He said the Health Minister has assured the association that he will make a statement on the Floor of the House to clarify the wrong impression created against locally made medicines.Rehman said this allegation has not only tarnished the image of national pharma industry in the country but the buyers have also sought clarification from us on this issue. It might affect our local sale and exports as well, he added.PPMA chief said that drug prices were raised by 3.5 percent in 2001 and since than no price rise was allowed by the government. The price increase was allowed only in "hardship cases" between 2007 and 2008, he added.He said that during this period from 2001 to 2010, the prices of raw materials and other inputs including electricity, gas and petroleum prices has surged manifold. The devaluation of Pak rupee by more than 60 percent has also inflated raw material prices, he observed. Former Chairman PPMA Zahid Saeed, Dr Kaiser Waheed, Regional Chairman, Tariq Ikram, Haroon Qasim, Dr A Shakoor, Shahzeh Akram, Hamid Raza, Mian Nasir Liaquat and others were also present on the occasion.

A Comprehensive  Report on Afghanistan's Pharma Market
By Mr. Zakiullah Khan GM Export Karachi,
Mr. Irfan Baig Country Sales Manager Peshawer,
Helix Pharma (Pvt) Karachi (19 - 24 Dec 2009)

Dec 19, 2009.

• Retail Market Survey

Areas: The Afghanan, Makrooyan, Karteparwan, Khairkhana, Shahr e Now, Hospital Pharmacies.

Chemists Called: Nasir Darmaltoon, Nabi Shamshad Darmaltoon, Wase Darmaltoon, Basharat Darmaltoon, Mohsin Darmaltoon,

• Doctor Visits

Dr. Yusuf “President Eye Association Afghanistan”

Dr. Muhd. Reshad Sadiqyar

Dr.Nazruddin Najam

Dr. Muhd. Alam Qahir

Dr. Najeebullah Toheedwal

• Meeting with “Helix’s Distributor” included, M/s Bait Nika Ltd. Kabul, Al-Kawsar Sherzay Ltd, Nabizada Pharma Co. Ltd. Jalalabad. Mr. Ghulam Rasool Gardez, Mr. Gulnawar Ghazni.(Mr. Haji Agha of Kandhar was not available due to performing of the  hajj)

Problems:  Insufficient Literature, Giveaway, Poor Quality of master cartoons, Empty blisters & Eye drops, Training of Medical Representatives, Product expiry should be 2 years,

Suggestions:  Commercial stocks should be 200 units in each cartoon & Eye drops should be 400 units, Wall hangings, panafax, posters, product list or product guide, Zomax caps 6’s packing alu alu blister confirm order by dr. yousaf & ghulam rasool of 20000 units, Tear substitute Eye Drops, Ferollic packing change like Ironal 20000 packs order by dr. yousaf, Vision Vit of sante specially demanding by Eye Doctors, Special support of company in Doctors activities, Area code should be suggested only,

• Meeting with Medical Representative of Helix.

Comments: We did very hard work for Helix & develop very well repute in Afghan Market. Helix has excellent product portfolio which is acceptable to Afghan doctors. Efficacy of the products has also been accepted. Helix can grow very well but it needs only competitive promotion.

Dec 20, 2009.

• Whole Sale Market Survey & Meetings with “other Distributors”

Markets: Qadir Bakhshi, Parwan Hotel, Sehat Market, Ilham Firdous, Shamshad, Indian, Irani, Chines, Bangladesh & Medical Equipments.

• Meeting with other companies medical reps.

Companies are not implementing promotional policies just like Pakistan. Getz, Nabiqasim & multinational are implementing the same that why getting desire results. 

• Meeting with “Arian Asia Pharma Co. Ltd.” (Sole Agent Searle)

The Sales of Searle are 30 to 40 lacks per month new products are not selling. Searle is 16 year old company in Afghanistan but now a day they are losing their credibility in Afghan Market.

• Meeting with “Bashir Tahir Saharzai Ltd Group of Kawser Asia+Afghan Tolo

(Sole Agent Genix, Bosch, Z-Jan, Scottman, Biogenic, Highnoon, Willson, Werrick, Scottman.)

They are financially very sound. We have detailed our proposal with Mr. Naseem one of the important director of this company. He commit after the discussion with others directors of the company, he will come to Peshawar or Karachi to finalize the matter.

• Visit to Ministry of Health Kabul

Advise by registration department of the Ministry of Public Health Kabul.

“Helix should prepare their missing Drug Master Files other wise it may cause the cancellation of registered drugs”

Dec 21, 2009.

• Leading Hospital’s Visit

Al-Noor Eye Hospital, Bilsum Hospital, Rabia Balkhi Hospital, Indragandhi Hospital, Laisa Maryam

• Meeting with “Rana Health Care” of Mr. Shahzad Haqqani

Rana Health care is a newly setup in Afghan Market. They are also working in professional manners. They can invest Rs. 10 millions although the Helix will start company parole promotion. Their detailed proposal also enclosed.

Dec 22, 2009

• Meeting with “Alhaj Mualim Mangal Pharma Co. Ltd.”

Distributor for Abbott, Getz, Merck, Pharmacia, Park Davis, Sandoz, Nabi Qasim, Serg, Scilife.

They are doing comparatively heavy work I mean working with very good sales

Producing companies. At the moment they are not interested to hire new company

For distribution.

• Meeting with “Mr. Dost Muhammad” c/o Stalwart Pharmaceutical Peshawar.

He did not meet our criteria.

•  “Wiyar Safi Ltd.”Distributor for CCL

They are very hardworking people in Afghanistan. We have also detailed our proposal with Mr. Abduwali Director Marketing of the said company.s

Comments: Our Chief Executive outside the country, I will discuss the proposal than meet with you in Karachi.

Dec 23, 2009.

• Market survey & Competitors Activities

Qadir Bakhshi, Parwan Hotel, Sehat Market, Ilham Firdous, Shamshad, Indian, Iranian, Chinese, Bangladesh, Turkish & Medical Equipments

 Companies Operating in Afghanistan                          Activity

Ú     Jalphar (UAE):                       Television, Refrigerator, Generator, Fans etc.         

Ú     Ekseer (Iran):                        Laptop to every potential doctor.

Ú     Bayer (Pakistan):                   Cash.

Ú     Nabi Qasim (Pakistan):         10% Doctor discount.

Ú     Merck (Pakistan):                 Medical Books, Doctor’s Pads.

Ú     Searle (Pakistan):                  Medical Books, Doctor’s Pads.

Ú     Global (Pakistan):                  Computers, Television, Refrigerator, Fans etc.

Ú     Saydon (Pakistan):                 Shirts, Pants, coats, overalls & Hospital services.

Ú     Z-Jan (Pakistan):                   Open Market Discount & Doctor activity of 30%

Ú     Getz (Pakistan):                    Getz has started full fledged activities like Pakistan. Getz started foreign tours to potential doctors of Afghanistan from his launching. It seems that soon Getz Pharma will leave behind all the companies in Afghanistan.

Ú     Turkish Companies:  Now a days Turkish companies seems in a good growing position. Most of the companies providing 10% cash payments to doctors. Along with cash they trying to oblige their customers both doctor & chemist. I am sending a few gifts of a newly launched MN Pharam Turkey.

Ú     Bangladeshi Companies: Most of the peoples like Bangla companies due to its economy and excellent packaging.

Ú     Chinese Companies:  They are promoting by local promoters only on the basis of cash.

Hospitals                                                   Strength

*Al-Noor Eye Hospital                     40-50  Eye Drs.

* Bilsum Hospital                                   35-50 Gen.Drs.

* Rabia Balkhi Hospital                        20-25 Gyn. Drs.

* Indragandhi  Hospital                        30-50 Paeds

* Laisa Maryam Hospital                      30-40 Gen.Drs.

* Jamhoriat (Army) Hospital                50-80 Gen.Drs.

* General Hospital (Ibne-Seena)           30-50 Gen.Drs

Population

 Total  :     40 millions  25 millions ( Citizens )  15 millions ( Refugees )

Pharma Business

 $ 2000 millions   $ 1200 millions (Importers)   $   800  millions ( NGO’s  )

Therapeutic Segment

Anti infective  Analgesics & Antipyretics  Respiratory System  Gastro-intestinal System Dermatological System   Nutrition   Sensory System / Eye Products etc.  Hospital Solutions           

Molecules

Amoxicillin Clavulanic Acid Cefixime Cefatoxime Sodium Ceftriaxone Cephradine Azithromycin Ofloxacin Ciprofloxacin Levofloxacin  Diclofenac Paracetamol  Losartan  Atorvastatin  Iron-Polymaltose  Resperido Omeparazole

Zafa Pharmaceutical arranged a seminar on"Use of Noreithisterone in Gynecological disorders"  Join ZAFA CLUB to serve the humanity. This club is basically for Proud Pakistani Doctors who believe in serving the country and think that every Human being / Every Pakistani has a right to live healthy life through easy access to medical facility just like ZAFA believes in "Medicine for all" All you have to do is send your information to Mr. Rashid Anwar , Business Unit Head at his cell 0333- 2321996 or email him at zafaph@cyber.net.pkThis is a free promotional activity of ZAFA & Jeevey Pakistan news website so that people could have an access to quality doctors for their medical issues. In this conection you can include your pics, clinic timing and information of free medical camps arranged at your clinics.

ZAFA Pharmaceuticals Laboratories (Private) Limited

Jeevey Pakistan has always focused such things which are the real signs of proud ness for Pakistan.In this connection we have chosen Pharmaceutical industry which is basically comprised of Multinationals and the local ones in common words. Jeevey Pakistan has selected a multinational Company to focus its those strengths which make Pakistan proud of it. The amazing thing is that this multinational company is not a foreign company working in Pakistan but it is a Pakistani company 

ZAFA Pharmaceuticals Laboratories (Private) Limited  

which is the 1st Pakistan Based Multinational Pharmaceutical  Company, It was founded in 1973, by it's present Chairman and Chief Executive, Mr. Muhammad Amin Khan. Their founder firmly believes in the theory of "MEDICINES FOR ALL", which has played  a key role in setting up the prices of their new introductions in the market. Zafa's motto is

"NOBODY SHOULD SUFFER FROM WANT OFMEDICATION"

 As it's been mentioned earlier that ZAFA is the 1st Pakistan based Multinational Pharmaceutical manufacturing concern with its own manufacturing facility based in Khartoum Sudan. In addition to this they have presence in various African, Middle Eastern and South American countries. Zafa is an ISO 9001:2000 certified manufacturing concern and has emerged as a leading Pharmaceutical Group of Companies that has brought the concept of Dedicated  Manufacturing  facilities in Pakistan.

Zafa is  presently ranked at #2 (By selling more than 60 million unit packs per annum)

 in Pakistan as per Unit Wise sales and is  operating with Nine (9 manufacturing facilities and two (2) to be commissioned soon. Today ZAFA's product range represents a wide category of therapeutic classes and is one of the few companies in the world to manufacture Insulin formulations (both Hunman and Bovine). Product range includes more than 300 products with another 30 in the pipeline, While 13 of their products are leaders in Pakistan as per Unit Wise sales.

The management  of Zafa has developed an internal quality audit plan to check the effectiveness of the command and control system and a cross facility team has been developed and trained to perform independent audits of different facilities within the group.

Other Unique features of Zafa

• ZAFA Shorab Goth is our most modern and latest Pharmaceutical Formulation Facility. It is one of the largest facilities, area wise in Pakistan, built on an area of 170,000 square feet.

• ZAFA Hormones Division is a dedicated facility for the manufacture of Hormonal products. It has been built on latest WHO and cGMP guidelines and is one of the few dedicated facilities operating around the world.

• Zafa's BALSAM Pharmaceutical, is the largest Pharmaceutical manufacturing concern of Sudan and is located at North Khartoum Industrial region.

Topic of the Week
Got an Interview?

Your skills will be the foundation of the strategy you use to ‘sell’ yourself to employers as exactly the type of candidate they want.
Your strengths are part of yourself, the beliefs, values, principles, and the personal qualities that distinguish you as an individual.
Recognize your strengths and weaknesses. Assess your skills and you will identify your strengths.
Think about your accomplishments, the things you have done that gave you enjoyment, satisfaction and rewards.
Use the STAR technique: Situation or Task, Action you took, Results you achieved.
Make a list of about five to ten of your accomplishments; start each with an action verb and try to quantify the results as much as possible.
For example: Create, Develop, Solve, Implement, Lead, Organize, Improve, Sell, Direct etc. If so, How Much? How Many? How soon? Etc.
And what happened as a result? How did the Business or the Organization benefit?
When you have the list, ask yourself what the specific skills and strengths were that you used in order to make this happen. Do a frequency count of your most used strengths and skills.
These will tell you who you are, what you enjoyed the most, and what helped result in the most satisfying and rewarding accomplishments.